Bio-Rad Laboratories BIO Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Clinical Diagnostics | $1.57B+2.8% | $1.56B+1.6% | $1.53B-0.3% | $1.53B+0.9% | $1.53B+1.3% | |
| Life Science | $1.02B+0.6% | $1.02B-0.7% | $1.03B-1.5% | $1.03B-1.9% | $1.02B-7.4% | |
| Net Sales by Geography | ||||||
| Americas | $170.7M+1.2% | $165.4M-2.3% | $162M-5.4% | $163.1M-6.8% | $168.6M+0.6% | |
| Asia Pacific | $519.6M+2.2% | $513.3M-1.6% | $497.9M-7.7% | $503.8M-5.2% | $508.6M-6.4% | |
| Europe | $888.8M+6.6% | $881.8M+5.7% | $860.9M+4.6% | $844.4M+4.2% | $833.7M+2.3% | |
| UNITED STATES | $1.01B-1.9% | $1.02B-1.8% | $1.04B-0.9% | $1.04B-0.3% | $1.03B-4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bio-Rad Laboratories break its business down?
- Bio-Rad Laboratories (BIO) reports net sales by business across 3 parts — All Other Segments, Clinical Diagnostics and Life Science. Each is extracted from the segment footnotes and tracked over time.
- Where does Bio-Rad Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bio-Rad Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
